IDEAYA Biosciences to Present at the 36th Annual J.P. Morgan Healthcare Conference

Friday, January 5, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

SAN FRANCISCO and SAN DIEGO, Jan. 5, 2018 /PRNewswire/ -- IDEAYA Biosciences, an oncology-focused

biotechnology company committed to the discovery of breakthrough small-molecule synthetic lethality and immuno-oncology therapies, today announced that Yujiro S. Hata, chief executive officer of IDEAYA, will present at the 36th Annual J.P. Morgan Healthcare
Conference in San Francisco at 1:30 p.m. PT on Wednesday, January 10.

About IDEAYA Biosciences

IDEAYA is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations and for enhancing immunotherapy response, and immuno-oncology therapies targeting the tumor micro-environment.  IDEAYA, located in South San Francisco and San Diego, California, has assembled leading scientists and advisors with extensive knowledge and expertise in cancer biology and small molecule drug discovery.  For more information, please visit www.ideayabio.com.

 

Cision View original content:http://www.prnewswire.com/news-releases/ideaya-biosciences-to-present-at-the-36th-annual-jp-morgan-healthcare-conference-300578037.html

SOURCE IDEAYA Biosciences, Inc.

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store